Speaker Profile
M.D., Ph.D., CEO/CSO, Epicentrx
Biography
Dr. Reid received his MD, Ph.D. from Stanford University. His academic research has focused on developing tumor-selective gene expression vectors and oncolytic viruses. His clinical research has focused on GI malignancies. He has been the director of the GI malignancy program, Clinical Trial Organization and Early Phase Clinical Research Program at UC San Diego. He is CEOCSO for Epicentrx Pharmaceuticals.
Talk
AdAPT-001 in Advanced Soft-Tissue Sarcoma (BETA PRIME)
The ubiquitously overexpressed cytokine transforming growth factor beta (TGF-β) is an immunosuppressive cytokine.In a Phase 12 trial we assessed AdAPT-001, an immunotherapy that delivers a TGF-β trap, which binds to and neutralizes TGF-β, both with and without checkpoint inhibitors in over 50 patients with refractory tumors. Most but not all tumors were advanced sarcomas
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Keynote: Engineering Synthetic T Cell States for Cancer Rejection
- George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford
- Lawrence Fong, UCSF - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: Jean Xu, Janssen Pharmaceuticals
- Amanda Pace, Sonoma Bio
- Laura Deschenes, Sana Biotechnology - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Emerging Clinical Data in Oncology Cell Therapeutics
Chair: Andrew Allen, Gritstone bio, Inc.
- Robert Meehan, Moderna - Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Robert Meehan, Moderna
- Dirk Nagorsen, Affini-T Therapeutics - AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
- Brian Weitzner, Outpace Bio
- PMWC Showcase
- Arun Wiita, UCSF
